Immunopotentiators in modern vaccines /

Saved in:
Bibliographic Details
Imprint:Amsterdam ; Boston : Elsevier/Academic Press, c2006.
Description:xi, 371 p. ; ill. ; 25 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5820400
Hidden Bibliographic Details
Other authors / contributors:Schijns, Virgil E. J. C.
O'Hagan, Derek T.
ISBN:9780120884032 (casebound : alk. paper)
0120884038 (casebound : alk. paper)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000pam a22000004a 4500
001 5820400
003 ICU
005 20061012122900.0
008 050607s2006 ne a b 001 0 eng
010 |a  2005016429 
020 |a 9780120884032 (casebound : alk. paper) 
020 |a 0120884038 (casebound : alk. paper) 
040 |a DNLM/DLC  |c DLC  |d DLC  |d NhCcYBP  |d UtOrBLW  |d OrLoB-B 
042 |a pcc 
050 0 0 |a QR187.3  |b .I56 2006 
060 1 0 |a QW 805  |b I337 2006 
082 0 0 |a 615/.372  |2 22 
245 0 0 |a Immunopotentiators in modern vaccines /  |c [edited] by Virgil E.J.C. Schijns, Derek O'Hagan. 
260 |a Amsterdam ;  |a Boston :  |b Elsevier/Academic Press,  |c c2006. 
300 |a xi, 371 p. ;  |b ill. ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Unraveling "the immunologist's dirty little secret" /  |r Virgil E. J. C. Schijns --  |g 2.  |t Dendritic cells as targets and tools in vaccines /  |r Imerio Capone, Paola Rizza and Filippo Belardelli --  |g 3.  |t Host-derived molecules as adjuvants /  |r Tom Barr, Jennifer Carlring and Andrew W. Heath --  |g 4.  |t Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants /  |r Achal Pashine, Jeffrey B. Ulmer and Nicholas M. Valiante --  |g 5.  |t CpG oligodeoxynucleotides as vaccine adjuvants /  |r Michael J. McCluskie and Risini D. Weeratna --  |g 6.  |t Toll-like receptor 4 agonists as vaccine adjuvants /  |r David H. Persing, Patrick McGowan, Jay T. Evans, Christopher Cluff, Sally Mossman, David Johnson and Jory R. Baldrige --  |g 7.  |t Immunomodulatory adjuvants from Quillaja saponaria /  |r Charlotte Read Kensil --  |g 8.  |t Microparticles as vaccine delivery systems /  |r Derek T. O'Hagan --  |g 9.  |t MF59 : a safe and potent adjuvant for human use /  |r Audino Podda, Giuseppe Del Giudice and Derek T. O'Hagan --  |g 10.  |t Development and evaluation of AS04, a novel and improved adjuvant system containing MPL and aluminum salt /  |r Nathalie Garcon, Marcelle Van Mechelen and Martine Wettendorff --  |g 11.  |t Virosomes for vaccine delivery /  |r Ian C. Metcalfe and Reinhard Gluck --  |g 12.  |t The ISCOMATRIX adjuvant /  |r Debbie Drane and Martin J. Pearse --  |g 13.  |t Mineral adjuvants /  |r Erik B. Lindblad --  |g 14.  |t Mucosal adjuvants based on cholera toxin and E. coli heat-labile enterotoxin /  |r Jan Holmgren, Cecil Czerkinsky, Ali M. Harandi, Michael Lebens and Jia-Bin Sun --  |g 15.  |t Transcutaneous immunization using the heat-labile enterotoxin of E. coli as an adjuvant /  |r Richard T. Kenney and Gregory M. Glenn --  |g 16.  |t T cell adjuvants and novel strategies for their identification /  |r Laurence Van Overvelt and Philippe Moingeon --  |g 17.  |t Vaccination to treat noninfectious diseases : surveying the opportunities /  |r Stephen W. Martin and Martin F. Bachmann --  |g 18.  |t Clinical evaluation of adjuvants /  |r Jakub K. Simon and Robert Edelman --  |g 19.  |t Regulatory considerations in the nonclinical safety assessment of adjuvanted preventive vaccines /  |r Elizabeth M. Sutkowski and Marion F. Gruber. 
650 0 |a Immunological adjuvants.  |0 http://id.loc.gov/authorities/subjects/sh85000895 
650 0 |a Immune response  |x Regulation.  |0 http://id.loc.gov/authorities/subjects/sh85064538 
650 0 |a Vaccines.  |0 http://id.loc.gov/authorities/subjects/sh85141718 
650 1 2 |a Vaccines  |x immunology. 
650 2 2 |a Adjuvants, Immunologic. 
650 2 2 |a Drug Delivery Systems. 
650 2 2 |a Immunotherapy. 
650 7 |a Immune response  |x Regulation.  |2 fast  |0 http://id.worldcat.org/fast/fst00967872 
650 7 |a Immunological adjuvants.  |2 fast  |0 http://id.worldcat.org/fast/fst00967992 
650 7 |a Vaccines.  |2 fast  |0 http://id.worldcat.org/fast/fst01163573 
700 1 |a Schijns, Virgil E. J. C.  |0 http://id.loc.gov/authorities/names/n97035181  |1 http://viaf.org/viaf/276645983 
700 1 |a O'Hagan, Derek T.  |0 http://id.loc.gov/authorities/names/n93804460  |1 http://viaf.org/viaf/54255508 
901 |a ToCBNA 
903 |a HeVa 
035 |a (OCoLC)60766955 
929 |a cat 
999 f f |i 1b76c6f2-20b0-5f50-af5d-54feddf7e737  |s 8f080206-742a-50f8-a5e5-7ca5d59df9d3 
928 |t Library of Congress classification  |a QR187.3 .I56 2006  |l JCL  |c JCL-Sci  |i 4991813 
927 |t Library of Congress classification  |a QR187.3 .I56 2006  |l JCL  |c JCL-Sci  |e CRERAR  |b 71099644  |i 7955191